Morocco: AMMPS Introduces a Dedicated Email Address for Health Vigilance Activities
Publication date: 5 January 2026
The Moroccan Agency for Medicines and Health Products (AMMPS) has issued a formal communication addressed to industrial pharmaceutical establishments and to organizations involved in the manufacturing, importation, exportation, and distribution of health products, announcing the implementation of a new dedicated email address for sanitary vigilance activities.
This measure forms part of the new organization of health vigilance activities in Morocco and aims to improve the efficiency, traceability, and processing of regulatory communications related to product safety.
A Centralized Communication Channel for Vigilance Activities
To strengthen the management of sanitary vigilance activities, the AMMPS has established a dedicated official email address for the submission and handling of all documents and correspondence related to vigilance obligations.
Official email address:
vigilances.industries@ammps.gov.ma
This address will serve as the single official communication channel between regulated establishments and the AMMPS for vigilance-related matters.
Scope and Stakeholders Concerned
The communication applies to:
Industrial pharmaceutical establishments;
Establishments involved in the manufacture, import, export, and distribution of health products, including medicines, Medical Devices and other regulated products.
All entities subject to Moroccan vigilance requirements are expected to use this channel for communications related to pharmacovigilance, materiovigilance, and other applicable vigilance systems.
Entry into Force and Regulatory Expectations
The official use of the new email address will become mandatory as of 12 January 2026.
From that date onward:
All correspondence related to sanitary vigilance activities must be sent exclusively to the dedicated AMMPS email address;
Submissions sent via other channels may no longer be considered valid or processed.
This change is intended to enhance regulatory efficiency, traceability of exchanges, and timely processing of vigilance-related information.
Contribution to Public Health Protection
Through this initiative, the AMMPS reaffirms its commitment to ensuring the safe use of medicines and health products across the national territory. Centralizing vigilance communications supports more effective monitoring, faster regulatory response, and improved coordination with regulated stakeholders.
The AMMPS also expressed its appreciation to all pharmaceutical and health product establishments for their continued cooperation in maintaining a high level of public health protection in Morocco.
Regulatory Impact for Industry Stakeholders
Pharmaceutical companies and health product operators active in Morocco should:
Update their internal vigilance procedures;
Inform relevant teams (regulatory affairs, pharmacovigilance, QA) of the new communication requirement;
Ensure that all future vigilance-related submissions comply with this new process as of 12 January 2026.
Failure to comply with official communication channels may result in delays or non-processing of vigilance notifications.
Conclusion and Regulatory Support Services
The introduction of a dedicated email address for sanitary vigilance communications reflects the AMMPS’s ongoing efforts to strengthen the organization, traceability, and effectiveness of vigilance systems in Morocco. This regulatory update has direct operational implications for pharmaceutical and health product establishments, particularly in terms of internal procedures, documentation workflows, and regulatory responsiveness.
Ensuring that vigilance-related communications are sent through the appropriate official channel as of 12 January 2026 is essential to avoid delays, missed notifications, or non-compliance with Moroccan regulatory requirements.
Simon MedTech Solutions supports pharmaceutical companies and health product operators active in Morocco with:
Review and alignment of pharmacovigilance and vigilance procedures with current AMMPS requirements
Assessment of internal workflows for vigilance reporting and regulatory correspondence
Support in the preparation, review, and submission of vigilance-related documentation
Regulatory intelligence and monitoring of AMMPS updates
Liaison support with Moroccan health authorities for vigilance-related matters
Our approach is pragmatic, compliance-driven, and tailored to both local and international operators navigating the Moroccan regulatory landscape.
Contact us to ensure your vigilance activities and regulatory communications remain fully compliant with AMMPS requirements.
